Bhagwan Yadav - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bhagwan Yadav

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

The Journal of Biological Chemistry|August 23, 2012

Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infectionOxana V Denisova, Laura Kakkola, Lin Feng, et al.

Leukemia|August 4, 2022

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemiaTiina Kelkka, Mikko Tyster, Sofie Lundgren, et al.

The Journal of Clinical Investigation|September 1, 2022

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemiaJani Huuhtanen, Mette Ilander, Bhagwan Yadav, et al.

Cancer Discovery|November 18, 2021

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.

Nature Communications|April 21, 2018

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic targetOlli Dufva, Matti Kankainen, Tiina Kelkka, et al.

Cancer Discovery|September 24, 2013

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemiaTea Pemovska, Mika Kontro, Bhagwan Yadav, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

The Journal of Biological Chemistry|August 23, 2012

Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infectionOxana V Denisova, Laura Kakkola, Lin Feng, et al.

Leukemia|August 4, 2022

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemiaTiina Kelkka, Mikko Tyster, Sofie Lundgren, et al.

The Journal of Clinical Investigation|September 1, 2022

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemiaJani Huuhtanen, Mette Ilander, Bhagwan Yadav, et al.

Cancer Discovery|November 18, 2021

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.

Nature Communications|April 21, 2018

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic targetOlli Dufva, Matti Kankainen, Tiina Kelkka, et al.

Cancer Discovery|September 24, 2013

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemiaTea Pemovska, Mika Kontro, Bhagwan Yadav, et al.

Pageof 4